Amazon said it will make its healthcare AI assistant available to customers accessing the retail giant's services via its website and mobile app, with the aim of simplifying care for more than 30 conditions.
The model, which the company first announced in January, had previously been reserved for members of One Medical, the clinical services organization owned by Amazon. The expanded tool is free to customers and does not require membership in Prime, the company’s premium prescription service, or One Medical.
Capabilities and scope
According to Amazon, the assistant can explain medical test results, respond to questions about medications and symptoms, and link patients with healthcare providers when necessary. For a set of non-emergency conditions - examples cited by the company include acne, head lice, diabetes and sleep apnea - the agent can assist with symptom management, conduct virtual assessments, and offer treatment advice.
Andrew Diamond, chief medical officer at Amazon One Medical, said the tool is intended to reduce logistical and informational barriers in healthcare so that patients and providers can concentrate on clinical priorities. "Health AI is designed to handle the logistical and informational work that creates friction in healthcare, so patients and providers can spend more time on what matters most," he said.
Limitations and provider handoffs
A company spokesperson emphasized that the assistant does not create formal treatment plans. When a patient's condition is complex or requires specific treatment, the assistant will connect that patient with a human provider. For visits that do require a provider, the company said those appointments cost $29 each for patients who are not One Medical members or not using an introductory Prime offer.
Data access and integration
Customers who choose to do so can grant the assistant permission to access medical data, including laboratory results, medical records and clinical notes. The assistant is also able to review healthcare-related purchases made on Amazon, such as vitamins or blood pressure monitors, and use that information to ask follow-up questions.
Additional service context
The company framed the assistant as a way to handle routine informational and logistical tasks in the care pathway, rather than to replace clinicians. When cases exceed the assistant's scope, the handoff to a provider and the stated visit price for non-members remain in effect.
Third-party evaluation reference
The company referenced an external evaluation product that assesses stocks, saying the assessment tool evaluates AMZN alongside thousands of other companies monthly using more than 100 financial metrics. That evaluation system claims to look beyond popularity to weigh fundamentals, momentum and valuation, and cites prior notable winners in its strategies, naming Super Micro Computer (+185%) and AppLovin (+157%) as examples. The company suggested customers can check whether AMZN appears in any of those strategies or whether alternative opportunities exist in the same space.